Marshall Wace
PDSB icon

Marshall Wace’s PDS Biotechnology PDSB Stock Holding History

Marshall Wace’s Portfolio PDSB Stock Details PDSB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-68,454
Closed -$91K – 3282
2025
Q2 		$91K Buy
+68,454
New +$93K ﹤0.01% 2553
2025
Q1 		– Sell
-39,024
Closed -$63.6K – 2979
2024
Q4 		$63.6K Buy
39,024
+10,837
+38% +$28.7K ﹤0.01% 2475
2024
Q3 		$108K Buy
+28,187
New +$94K ﹤0.01% 2367
2024
Q2 		– Sell
-41,221
Closed -$163K – 2853
2024
Q1 		$163K Buy
+41,221
New +$212K ﹤0.01% 2260
2023
Q4 		– Sell
-68,795
Closed -$347K – 2501
2023
Q3 		$347K Sell
68,795
-4,425
-6% -$24.2K ﹤0.01% 1834
2023
Q2 		$368K Sell
73,220
-65,788
-47% -$431K ﹤0.01% 2081
2023
Q1 		$855K Buy
139,008
+103,376
+290% +$846K ﹤0.01% 1890
2022
Q4 		$470K Buy
35,632
+8,034
+29% +$56.7K ﹤0.01% 2401
2022
Q3 		$82K Sell
27,598
-49,147
-64% -$209K ﹤0.01% 3206
2022
Q2 		$281K Sell
76,745
-93,734
-55% -$446K ﹤0.01% 3054
2022
Q1 		$1.06M Buy
170,479
+101,550
+147% +$631K ﹤0.01% 2428
2021
Q4 		$557K Buy
68,929
+10,756
+18% +$116K ﹤0.01% 2742
2021
Q3 		$867K Buy
+58,173
New +$725K ﹤0.01% 2105
2021
Q2 		– Sell
-44,232
Closed -$201K – 2976
2021
Q1 		$201K Buy
+44,232
New +$178K ﹤0.01% 2260

Other funds holding PDSB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IWA
Inspirion Wealth Advisors Libertyville, Illinois $874M AUM 16.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Marshall Wace's PDSB Position: Q3 2025 in Review

Marshall Wace sold out of PDS Biotechnology (PDSB) in Q3 2025, closing a stake of 68,454 shares — an estimated $91K sold.

Marshall Wace first reported a position in PDSB in Q1 2021 and held it in 14 quarters. The position peaked at $1.06M in Q1 2022. 47 funds tracked by Wall St. Rank hold PDSB as of Q3 2025.

  • Marshall Wace reported no remaining PDS Biotechnology position as of Q3 2025 after selling out during the quarter.
  • Marshall Wace sold 68,454 PDS Biotechnology shares in Q3 2025, an estimated $91K.
  • Marshall Wace first reported a position in PDS Biotechnology in Q1 2021 and held it in 14 quarters.
  • Marshall Wace's PDS Biotechnology position peaked at $1.06M in Q1 2022.
  • 47 funds tracked by Wall St. Rank held PDS Biotechnology as of Q3 2025.

Based on Marshall Wace's 13F filing for Q3 2025, filed 13 Nov 2025.